MedTrace Logo

Does Residual Muscular Weakness Lead to an Increase in Respiratory Complications in Bariatric Patients?

NCT02037516 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 330

Last updated 2016-02-05

No results posted yet for this study

Summary

The purpose of this study is to determine if residual weakness after weight loss surgery leads to an increased risk of respiratory complications in the postoperative period.

Conditions

  • Respiratory Complication
  • Morbid Obesity

Interventions

DEVICE

Accelomyography

quantitative measurement of the train-of-four with the TOF Watch to determine timing of administration of neostigmine and extubation To assure patient flow the time to reversal administration will be limited to approximately 30 minutes after achieving 4 twitches in qualitative monitoring

DRUG

Neostigmine

Neostigmine is used to reverse the effects of neuromuscular blocking agents

DEVICE

Qualitative Monitor

Qualitative (tactile or visual) assessment of residual neuromuscular paralysis

Sponsors & Collaborators

  • Coastal Anesthesiology Consultants

    lead OTHER

Principal Investigators

  • Patrick Ziemann-Gimmel, MD · Coastal Anesthesiology Consultants

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02037516 on ClinicalTrials.gov